Servier

Servier

3y

We’re pleased to announce a strategic partnership 🤝 with Google Cloud. In line with our digital transformation, this agreement is centered around the use of data and artificial intelligence and aims to increase our innovation capabilities to serve patient needs. Google Cloud will provide us with the use of cloud storage spaces, as well as innovative tools with exceptional computing power and the possibility to accelerate data analysis and understanding through the use of AI. As Virginie Dominguez, Executive Vice President Digital, Data and Information Systems, stated: 🗣️ “Data and artificial intelligence are opening up tremendous prospects for drug discovery, disease prevention, and improved treatment adherence across the entire pharmaceutical value chain. ”...Show more

Servier

3y

We invest over 50% of our R&D budget in #oncology. Our research is focused on hard-to-treat cancers to address high unmet medical needs among patients. Listen to Des Murphy Head of Global Medical & Patient Affairs Oncology, describe our commitments to patients....Show more

Servier

3y

Today is World Humanitarian Day! 🤝 Mécénat Servier is involved with NGOs, such as La Chaîne de l'Espoir, which works to strengthen the health system for children, and TECHO, which helps families in extreme poverty. Thanks to Servier's support, 20 homes and several eco-toilets have been built with TECHO . The program supported by Mécénat Servier and its volunteers includes the construction of 34 emergency houses, two eco-toilets and a community center in several Latin American countries. Last year, more than 50 children underwent surgery at the Cuomo Pediatric Cardiology Center in Dakar thanks to the collaboration between Mécénat Servier and La Chaîne de l'Espoir. This partnership also encourages strengthening the skills of the center's medical and paramedical teams in order to ensure quality care. Join us for a healthier future! 🌍...Show more

Servier

3y

We’re thrilled to share that we officially opened our new R&D Center in the Seaport of Boston, MA – the epicenter of scientific innovation and development. This space further strengthens and expands our oncology presence in the U.S. market, fueling the next generation of scientific discovery. Our CEO and Chairman, Olivier Laureau spoke with Fierce Biotech about what this expansion means for Servier....Show more

Servier

3y

For several years, we have been committed to treating Chronic Venous Disease and hemorrhoidal disease, partnering with healthcare professionals 👩‍⚕️🧑‍⚕️. Venous disease is one of the most common diseases in the developed world, affecting up to 60% of adults over the age of 50. This July, we’re back 🚀🔥 with a new season of our awareness campaign. ...Show more